Best Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.
Industry: Biotechnology
F
Biotech is Zen Rated F and is the 138th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLXN | SILEXION THERAPEUTICS CORP | $3.61 | -11.30% | -49.15% | -50.14% | -71.41% | -81.20% | -97.10% | -99.73% | N/A | N/A | $131.40 | $3.55 | 97.25% | 1.69% | 0.48 | 521,000 | -54.30% |
| ADIL | ADIAL PHARMACEUTICALS INC | $0.35 | 0.00% | 0.29% | -11.17% | 7.69% | -51.92% | -67.89% | -97.12% | -98.95% | N/A | $1.30 | $0.22 | 73.08% | 59.09% | 0.70 | 1,052,000 | 0.29% |
| XTLB | XTL BIOPHARMACEUTICALS LTD | $1.20 | -11.11% | -6.98% | -14.89% | -1.64% | -6.25% | -52.76% | -11.11% | -44.70% | -86.86% | $2.59 | $0.86 | 53.67% | 39.53% | 0.65 | 18,000 | 339.02% |
| AEON | AEON BIOPHARMA INC | $0.79 | 1.28% | 8.97% | 2.86% | -7.17% | 8.22% | -98.46% | -99.89% | N/A | N/A | $115.57 | $0.38 | 99.32% | 110.67% | 0.22 | 120,000 | -30.23% |
| TRML | TOURMALINE BIO INC | $47.65 | 0.08% | 57.89% | 111.12% | 151.19% | 160.95% | 136.83% | 25.73% | N/A | N/A | $47.70 | $11.56 | 0.10% | 312.20% | 1.23 | 924,000 | -6.48% |
| NBTX | NANOBIOTIX SA | $9.32 | -3.91% | 6.97% | 17.83% | 86.77% | 178.21% | 89.05% | 119.29% | N/A | N/A | $10.59 | $2.76 | 11.99% | 237.68% | 0.95 | 5,100 | -7.27% |
| VANI | VIVANI MEDICAL INC | $1.27 | 4.96% | -0.78% | 1.60% | 11.40% | 15.45% | 0.79% | -52.96% | -50.47% | -99.45% | $1.80 | $0.91 | 29.44% | 40.33% | 1.13 | 43,300 | -2.48% |
| TRAW | TRAWS PHARMA INC | $2.07 | 8.38% | 11.29% | 37.09% | 26.99% | -21.89% | -75.65% | -92.92% | -97.62% | -100.00% | $19.44 | $0.97 | 89.35% | 113.40% | 0.93 | 256,000 | 72.97% |
| PHGE | BIOMX INC | $0.49 | 2.53% | -2.40% | -12.72% | 19.07% | -20.16% | -50.56% | -90.81% | -99.19% | N/A | $1.16 | $0.34 | 58.05% | 43.24% | 0.50 | 157,000 | -56.39% |
| TOVX | THERIVA BIOLOGICS INC | $0.41 | -0.24% | 6.70% | -10.00% | -11.35% | -65.21% | -89.25% | -98.80% | -99.66% | -100.00% | $4.20 | $0.37 | 90.14% | 12.50% | 0.79 | 200,000 | 41.84% |
| RANI | RANI THERAPEUTICS HOLDINGS INC | $0.49 | -2.40% | -2.40% | -11.27% | -6.15% | -68.31% | -78.60% | -94.64% | N/A | N/A | $3.75 | $0.39 | 86.99% | 26.10% | 1.12 | 264,000 | 30.05% |
| PALI | PALISADE BIO INC | $0.59 | -1.00% | 3.68% | -26.09% | -3.43% | -30.68% | -84.94% | -99.47% | -99.98% | -100.00% | $4.32 | $0.53 | 86.29% | 11.70% | 1.16 | 246,000 | 26.15% |
| ASBP | ASPIRE BIOPHARMA HOLDINGS INC | $0.41 | -3.06% | -19.53% | 14.76% | 16.71% | -35.32% | -96.40% | -95.92% | N/A | N/A | $15.80 | $0.22 | 97.39% | 91.63% | 0.44 | 887,000 | 51.11% |
| TENX | TENAX THERAPEUTICS INC | $6.09 | -0.33% | 0.83% | 2.01% | -0.33% | -2.25% | 61.11% | -98.54% | -99.77% | -99.99% | $7.89 | $3.25 | 22.81% | 87.38% | 0.43 | 8,200 | -6.82% |
| TCRT | ALAUNOS THERAPEUTICS INC | $2.25 | -2.60% | 2.74% | 0.00% | -29.60% | 53.06% | 4.65% | -99.29% | -99.49% | -99.86% | $6.20 | $1.31 | 63.71% | 71.23% | 1.17 | 43,000 | 26.47% |
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $1.37 | -2.14% | -1.44% | 3.79% | -36.57% | -29.74% | -80.29% | N/A | N/A | N/A | $12.45 | $1.22 | 89.00% | 12.76% | -0.41 | 24,200 | -13.57% |
| SYBX | SYNLOGIC INC | $1.65 | 3.46% | 11.90% | 11.15% | 35.95% | 23.68% | 15.85% | -90.38% | -94.97% | N/A | $1.96 | $0.90 | 16.07% | 83.18% | 0.83 | 31,800 | -32.34% |
| SPRB | SPRUCE BIOSCIENCES INC | $9.80 | -20.97% | 8.89% | 8.77% | 76.32% | -60.45% | -71.35% | -92.53% | N/A | N/A | $45.60 | $4.28 | 78.51% | 129.24% | 1.10 | 102,000 | 34.21% |
| YMAB | Y-MABS THERAPEUTICS INC | $8.61 | 0.23% | 0.23% | 1.06% | 74.29% | 80.88% | -33.82% | -40.62% | -78.13% | N/A | $16.11 | $3.55 | 46.55% | 142.54% | 1.49 | 761,000 | 45.51% |
| XRTX | XORTX THERAPEUTICS INC | $0.85 | 2.91% | 3.03% | 3.41% | -2.41% | -12.37% | -54.30% | -92.79% | N/A | N/A | $2.51 | $0.66 | 66.14% | 28.59% | 0.19 | 21,300 | -79.91% |
| SRZN | SURROZEN INC | $11.65 | 0.73% | 2.55% | 4.58% | 22.12% | 0.43% | 34.06% | -61.55% | N/A | N/A | $18.17 | $5.90 | 35.88% | 97.46% | 0.57 | 5,000 | 194.12% |
| VRNA | VERONA PHARMA PLC | $106.37 | -0.06% | 0.07% | 1.04% | 14.75% | 59.81% | 252.69% | 884.91% | 1,434.92% | N/A | $106.45 | $27.54 | 0.08% | 286.24% | 0.80 | 1,210,000 | 31.66% |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | $5.54 | -6.10% | 68.39% | 56.50% | 373.50% | 298.56% | -20.31% | -99.01% | -99.91% | -100.00% | $19.30 | $1.08 | 71.30% | 412.96% | 0.86 | 3,076,000 | -58.94% |
| XBIO | XENETIC BIOSCIENCES INC | $3.47 | -3.50% | 13.90% | 21.47% | 24.07% | -5.34% | -12.82% | -51.92% | -61.63% | N/A | $5.27 | $2.20 | 34.05% | 57.91% | 0.69 | 17,900 | -63.69% |
| QNRX | QUOIN PHARMACEUTICALS LTD | $7.82 | 2.89% | 3.44% | 4.55% | -7.13% | 28.20% | -37.00% | -99.17% | -99.97% | N/A | $31.40 | $3.33 | 75.10% | 134.98% | 2.26 | 2,900 | -12.12% |
| VTVT | VTV THERAPEUTICS INC | $20.41 | 3.29% | 8.80% | 32.19% | 28.45% | -10.25% | 43.13% | -55.63% | -73.83% | -94.35% | $26.99 | $12.62 | 24.38% | 61.73% | 0.85 | 5,600 | 300.00% |
| SER | SERINA THERAPEUTICS INC | $5.07 | -2.31% | -2.12% | -6.11% | -11.98% | 15.36% | -20.03% | -75.57% | -83.80% | N/A | $10.28 | $3.81 | 50.68% | 33.07% | 0.27 | 12,300 | -2.38% |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD | $1.63 | 4.49% | 7.24% | 2.52% | -25.91% | -51.42% | -51.49% | -98.34% | -99.96% | -99.57% | $6.18 | $1.40 | 73.62% | 16.43% | 0.84 | 89,000 | 21.92% |
| VYNE | VYNE THERAPEUTICS INC | $0.31 | -1.61% | 4.79% | -12.82% | -66.41% | -83.64% | -83.72% | -93.99% | -99.75% | N/A | $4.30 | $0.28 | 92.88% | 8.90% | 1.20 | 1,740,000 | 46.22% |
| SABS | SAB BIOTHERAPEUTICS INC | $2.10 | -0.94% | 0.00% | -5.41% | 23.53% | 29.63% | -22.22% | -74.56% | N/A | N/A | $6.60 | $1.00 | 68.18% | 110.00% | 0.65 | 136,000 | 122.95% |
| XBIT | XBIOTECH INC | $2.72 | -1.09% | -0.73% | -13.65% | -0.73% | -22.73% | -61.58% | -33.17% | -86.28% | -85.11% | $8.32 | $2.50 | 67.31% | 8.80% | 1.10 | 42,500 | 50.71% |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $0.43 | -2.26% | -4.00% | -20.00% | -43.38% | -60.73% | -63.08% | -81.50% | -95.99% | N/A | $4.28 | $0.30 | 89.91% | 44.00% | 0.66 | 945,000 | 20.23% |
| WHWK | WHITEHAWK THERAPEUTICS INC | $1.86 | -6.53% | 3.91% | 16.25% | -8.82% | -11.43% | -1.06% | -85.42% | -90.00% | N/A | $3.81 | $1.39 | 51.21% | 33.81% | 0.84 | 106,000 | -56.38% |
| SCPH | SCPHARMACEUTICALS INC | $5.61 | -0.36% | 0.54% | 21.96% | 40.60% | 87.00% | 1.81% | 19.36% | -28.72% | N/A | $6.28 | $1.94 | 10.67% | 189.18% | 0.99 | 847,000 | 105.58% |
| XCUR | EXICURE INC | $4.07 | 5.03% | -5.35% | -38.80% | -53.91% | -68.67% | 80.09% | -60.68% | -98.65% | N/A | $36.00 | $2.07 | 88.69% | 96.52% | 0.84 | 36,200 | -7.18% |
| PHAR | PHARMING GROUP NV | $13.89 | -5.38% | -4.34% | 19.23% | 22.74% | 57.84% | 78.08% | 18.72% | N/A | N/A | $17.08 | $7.31 | 18.68% | 90.01% | 0.53 | 13,200 | 94.12% |
| PLUR | PLURI INC | $4.90 | -0.81% | 3.59% | -1.49% | 15.29% | 3.73% | -6.72% | -29.60% | -93.66% | -97.15% | $7.13 | $3.33 | 31.28% | 47.15% | 0.85 | 3,300 | 26.92% |
| RPTX | REPARE THERAPEUTICS INC | $1.77 | 0.28% | 3.22% | 12.42% | 21.72% | 55.51% | -46.84% | -86.51% | -94.59% | N/A | $4.07 | $0.89 | 56.62% | 98.31% | 1.18 | 36,500 | -59.44% |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.